Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2023.216586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Kai Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Single-cell RNA-seq (scRNA-seq) and cancer organoid model have shown promise in investigating tumor microenvironment heterogeneity and facilitating chemotherapeutic drug testing to inform treatment selection. It is still unknown whether the scRNA-seq results based on organoid can faithfully reflect the heterogeneity of primary pancreatobiliary cancer. To reveal the similarities and differences between primary tumors and their matched organoids at transcriptome level, we conducted scRNA-seq for paired primary tumors and organoids from one cholangiocarcinoma (CCA) and two pancreatic ductal adenocarcinoma (PDAC) patients. We identified inter-patient and intra-tumor heterogeneity and found that the organoids retained copy number variation (CNV) patterns of primary tumors. There was no significant difference in cancer stem cell (CSC) properties between the primary tumors and the organoids, whereas organoid from one PDAC case had increased mesenchymal-score and decreased epithelial-score compared with the primary tumors. All organoids showed a transition tendency from the classical subtype to the basal-like subtype in the transcriptional level. Organoids and primary tumors differed in metabolic and unfolded protein response (UPR) signatures. In addition, we revealed the heterogeneity of cancer associated fibroblasts (CAFs) and T cells, and explored the developmental trajectory of T cells. Our findings facilitate further understanding of organoid model and confirm its application prospects in pancreatobiliary cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Peking University First Hospital, Beijing, China.
- Guangdong Research Center of Organoid Engineering and Technology, Accurate International Biotechnology Co Ltd., Guangzhou, China.
- Department of General Surgery, Peking University First Hospital, Beijing, China. Electronic address: tianxiaodong@pkufh.com.
- CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Center for Excellence in Nanoscience, National Center for Nanoscien…
- Department of General Surgery, Peking University First Hospital, Beijing, China. Electronic address: YangyinmoSCI@bjmu.edu.cn.
Zitieren
APA
Chen, K., Ma, Y., Zhong, X., Lan, J., Long, D., Tian, X., Yang, Y., & Yang, Y. (2024). Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216586
Vancouver
Chen K, Ma Y, Zhong X, Lan J, Long D, Tian X, et al. Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer. Cancer Letters. 2024. doi:10.1016/j.canlet.2023.216586
BibTeX
@article{Chen2024,
author = {Chen, Kai and Ma, Yongsu and Zhong, Xiejian and Lan, Jianqiang and Long, Di and Tian, Xiaodong and Yang, Yanlian and Yang, Yinmo},
title = {Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2023.216586}
}
EUVIMED